Polyostotic fibrous dysplasia with contrasting responses to calcitonin and mithramycin: aetiological and therapeutic implications.
Long
A
A
Loughlin
T
T
Towers
R P
RP
McKenna
T J
TJ
D000293:Adolescent; D000469:Alkaline Phosphatase / Q000097:blood; D002116:Calcitonin / Q000627:therapeutic use*; D002118:Calcium / Q000652:urine; D005357:Fibrous Dysplasia of Bone / Q000188:drug therapy*; D005359:Fibrous Dysplasia, Polyostotic / Q000188:drug therapy* / Q000201:enzymology; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D008297:Male; D010010:Osteoclasts / Q000187:drug effects; D008926:Plicamycin / Q000627:therapeutic use*
D002116:Calcitonin; D000469:Alkaline Phosphatase; D008926:Plicamycin; D006909:Hydroxyproline; D002118:Calcium